홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

1,2-Dichloroethane → 4-(4-((R)-(4'-chlorobiphenyl-2-yl)(dimethylamino)methyl)piperidin-1-yl)-N-(4-((R)-4-morpholino-1-(phenylthio)butan-2-ylamino)-3-(trifluoromethylsulfonyl)phenylsulfonyl)benzamide, hydrochloride salt

HRID 1476358
인쇄

반응식

HRID 1476358 반응식
[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([C:8]2[CH:13]=[CH:12][CH:11]=[CH:10][C:9]=2[C@H:14]([N:30]([CH3:32])[CH3:31])[CH:15]2[CH2:20][CH2:19][N:18]([C:21]3[CH:29]=[CH:28][C:24]([C:25]([O-])=[O:26])=[CH:23][CH:22]=3)[CH2:17][CH2:16]2)=[CH:4][CH:3]=1.[Li].C(Cl)CCl.CCN(C(C)C)C(C)C.[O:47]1[CH2:52][CH2:51][N:50]([CH2:53][CH2:54][C@@H:55]([NH:64][C:65]2[CH:70]=[CH:69][C:68]([S:71]([NH2:74])(=[O:73])=[O:72])=[CH:67][C:66]=2[S:75]([C:78]([F:81])([F:80])[F:79])(=[O:77])=[O:76])[CH2:56][S:57][C:58]2[CH:63]=[CH:62][CH:61]=[CH:60][CH:59]=2)[CH2:49][CH2:48]1.Cl>CN(C1C=CN=CC=1)C.C(Cl)Cl.CO.C(OCC)C>[ClH:1].[Cl:1][C:2]1[CH:3]=[CH:4][C:5]([C:8]2[CH:13]=[CH:12][CH:11]=[CH:10][C:9]=2[C@H:14]([N:30]([CH3:32])[CH3:31])[CH:15]2[CH2:20][CH2:19][N:18]([C:21]3[CH:22]=[CH:23][C:24]([C:25]([NH:74][S:71]([C:68]4[CH:69]=[CH:70][C:65]([NH:64][C@H:55]([CH2:54][CH2:53][N:50]5[CH2:51][CH2:52][O:47][CH2:48][CH2:49]5)[CH2:56][S:57][C:58]5[CH:59]=[CH:60][CH:61]=[CH:62][CH:63]=5)=[C:66]([S:75]([C:78]([F:81])([F:79])[F:80])(=[O:77])=[O:76])[CH:67]=4)(=[O:72])=[O:73])=[O:26])=[CH:28][CH:29]=3)[CH2:17][CH2:16]2)=[CH:6][CH:7]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

11

반응물 6

HCID 111,2-DichloroethaneHCID 313Hydrochloric AcidHCID 81531DiisopropylethylamineHCID 3028194LithiumHCID 250584544-[[(1R)-3-(4-Morpholinyl)-1-[(phenylthio)methyl]propyl]amino]-3-[(trifluoromethyl)sulfonyl]benzenesulfonamide2회HCID 131732793(R)-4-(4-((4'-chlorobiphenyl-2-yl)(dimethylamino)methyl)piperidin-1-yl)benzoate

생성물 1

HCID 1317327924-(4-((R)-(4'-chlorobiphenyl-2-yl)(dimethylamino)methyl)piperidin-1-yl)-N-(4-((R)-4-morpholino-1-(phenylthio)butan-2-ylamino)-3-(trifluoromethylsulfonyl)phenylsulfonyl)benzamide, hydrochloride salt수율 35%

시약·촉매·용매 4

HCID 142844-(Dimethylamino)pyridine촉매HCID 887Methanol용매HCID 3283Diethyl Ether용매HCID 6344Dichloromethane용매2회

실험 절차

(R)-4-(4-((4′-chlorobiphenyl-2-yl)(dimethylamino)methyl)piperidin-1-yl)benzoate, lithium salt (EXAMPLE 36, STEP 1, 0.105 g, 0.23 mmol), DMAP (56 mg, 0.46 mmol), and EDC (0.176 g, 0.92 mmol) were placed in a 40 ml vial and flushed with nitrogen. DCM (4.5 ml) and DIPEA (0.08 ml, 0.46 mmol) were added, and the solution was stirred at r.t for 15 minutes. (R)-4-(4-morpholino-1-(phenylthio)butan-2-ylamino)-3-(trifluoromethylsulfonyl)benzenesulfonamide (INTERMEDIATE 69, 0.127 g, 0.23 mmol) was added to the solution and the reaction mixture was stirred at r.t overnight. The reaction mixture was diluted with DCM and washed with 1N sodium bisulfate (aq.) followed by saturated aq. sodium bicarbonate. The organic layer was dried (Na2SO4), filtered, and evaporated under reduced pressure to give a residue which was purified by reverse phase HPLC (Gilson column, eluting with 30→50% H2O/ACN with 0.1% formic acid for 10 minutes) to provide a solid. The solid was dissolved in MeOH and the mixture was treated with 2N HCl in diethylether. Evaporation of the volatiles under reduced pressure provided the title compound (85 mg, yield: 35% for 2 steps).

후처리

  1. customflushed with nitrogen
  2. stirringthe reaction mixture was stirred at r.t overnight
  3. washwashed with 1N sodium bisulfate (aq.)
  4. dry with materialThe organic layer was dried (Na2SO4)
  5. filtrationfiltered
  6. customevaporated under reduced pressure
  7. customto give a residue which
  8. customwas purified by reverse phase HPLC (Gilson column, eluting with 30→50% H2O/ACN with 0.1% formic acid for 10 minutes)
  9. customto provide a solid
  10. customEvaporation of the volatiles under reduced pressure

출처 및 근거

ORD 기록
ord-b2ed97347c4b4b0e93641958c2edde44
출처 데이터셋
uspto-grants-2015_04
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US09018381B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트